No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2552 |
4. Check minimum number of eventsNone |
2552 |
5. Include endpointsNone |
2552 |
6. Filter based on genotype QC (FinnGen only) |
2552 |
Control definitions (FinnGen only)
- Control exclude
- K11_LIVER
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- K70-K77
- Name in latin
- Alii morbi inflammatorii hepatis
Other inflammatory liver diseases
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 19596 | 10245 | 9148 |
| Only index persons | 16233 | 8849 | 7384 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.27 | 0.29 | 0.26 |
| Only index persons | 0.31 | 0.33 | 0.28 |
| Median age at first event (years) | |||
| Whole population | 52.11 | 54.22 | 49.73 |
| Only index persons | 50.76 | 52.78 | 48.34 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2552 | 1462 | 1090 |
| Unadjusted period prevalence (%) | 0.49 | 0.50 | 0.48 |
| Median age at first event (years) | 51.01 | 50.75 | 51.35 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2326
- Matched controls
- 23254
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
+∞
323.0
1519
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
54.3
323.0
452
103
K75.0
ICD-10 Finland
Abscess of liver
+∞
287.6
270
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
9.6
284.0
640
884
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
2726.3
268.9
255
*
K75.4
ICD-10 Finland
Autoimmune hepatitis
+∞
260.4
245
*
K76.9
ICD-10 Finland
Liver disease, unspecified
392.2
250.8
248
7
A05AA02
ATC
ursodeoxycholic acid; oral
48.1
210.1
257
60
57300
ICD-8 Finland
Other diseases of liver, Hepatitis NUD
+∞
207.4
196
*
L04AX01
ATC
azathioprine; systemic
10.6
176.2
363
400
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.0
164.4
617
1574
K75.2
ICD-10 Finland
Nonspecific reactive hepatitis
1363.8
133.7
129
*
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
32.9
131.2
174
57
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
1330.2
130.5
126
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.1
125.2
940
4167
K74.3
ICD-10 Finland
Primary biliary cirrhosis
+∞
125.1
119
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
+∞
111.3
106
*
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
20.7
110.9
168
87
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
21.4
108.2
162
81
A07EA06
ATC
budesonide; oral, local oral
8.9
106.7
239
296
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.1
105.3
464
1325
K83.0
ICD-10 Finland
Cholangitis
19.9
102.9
158
85
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
848.0
84.1
82
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
16.6
80.8
132
84
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
37.6
78.9
101
28
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
9.8
78.0
163
177
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
73.0
885
4801
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
72.0
381
1238
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
9.0
71.9
158
187
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
70.1
958
5480
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
74.1
69.6
79
11
H02AB06
ATC
prednisolone; systemic
2.2
69.1
1207
7706
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
68.7
1108
6824
R50.9
ICD-10 Finland
Fever, unspecified
3.0
67.3
450
1724
A02BC02
ATC
pantoprazole; systemic
2.2
64.8
1583
11550
K70.1
ICD-10 Finland
Alcoholic hepatitis
634.8
63.1
62
*
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
+∞
62.8
60
*
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
131.5
60.1
64
5
N02AX02
ATC
tramadol; systemic, rectal
2.1
57.8
1063
6752
Z94.4
ICD-10 Finland
Liver transplant status
104.4
56.1
61
6
K75.3
ICD-10 Finland
Granulomatous hepatitis, not elsewhere classified
+∞
54.4
52
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
53.7
572
2824
B18.2
ICD-10 Finland
Chronic viral hepatitis C
14.0
53.5
93
69
R94.5
ICD-10 Finland
Abnormal results of liver function studies
13.8
52.7
92
69
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.5
52.6
467
2091
K72.9
ICD-10 Finland
Hepatic failure, unspecified
184.1
52.1
54
*
UJK02
NOMESCO Finland
ERCP
7.0
50.8
130
195
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
8.8
50.6
111
131
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
+∞
49.1
47
*
UJF32
NOMESCO Finland
Coloscopy
2.1
48.8
673
3720
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
48.3
312
1149
K71.2
ICD-10 Finland
Toxic liver disease with acute hepatitis
+∞
48.1
46
*
K75.8
ICD-10 Finland
Other specified inflammatory liver diseases
+∞
47.0
45
*
L01BB02
ATC
mercaptopurine; oral
13.9
46.7
81
60
C03DA01
ATC
spironolactone; oral
3.0
46.5
298
1091
JJC00
NOMESCO Finland
Allogenic transplantation of liver
163.3
46.0
48
*
L04AA06
ATC
mycophenolic acid; systemic
8.1
43.2
100
129
A06AD11
ATC
lactulose; oral
2.5
41.2
369
1642
J01MA12
ATC
levofloxacin; systemic
2.2
40.4
474
2406
J01MA02
ATC
ciprofloxacin; systemic
1.9
40.2
914
6023
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.6
40.1
327
1380
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
7.7
38.2
91
123
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.7
38.0
134
297
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.6
37.8
307
1290
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
21.6
37.5
55
26
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
12.7
37.3
67
54
B19.9
ICD-10 Finland
Unspecified viral hepatitis without hepatic coma
71.1
37.0
42
6
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
132.1
36.8
39
*
L04AD01
ATC
ciclosporin; systemic
7.1
36.6
92
135
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
36.0
426
2159
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
35.1
229
841
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
8.3
34.6
78
97
D97
ICPC
Liver disease NOS
25.8
34.5
48
19
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
13.0
34.4
61
48
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.2
34.4
196
658
UJF30
NOMESCO Finland
Ileoscopy through colon
2.6
33.6
269
1116
C03CA01
ATC
furosemide; systemic
1.9
33.6
603
3606
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
9.2
33.1
70
78
127
Kela drug reimbursment
Transplant complication
8.2
33.1
75
94
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
32.7
178
577
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.9
32.7
211
769
K51.5
ICD-10 Finland
Left sided colitis
5.2
32.3
103
205
ZX120
NOMESCO Finland
Intravenous
2.6
32.0
253
1041
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
31.7
368
1843
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
12.0
29.9
55
47
P01AB01
ATC
metronidazole; oral, rectal
1.7
29.6
909
6402
A07EC02
ATC
mesalazine; oral, rectal
3.2
29.2
165
549
H02AB07
ATC
prednisone; oral
2.1
28.9
355
1815
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.8
28.8
201
769
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
28.7
515
3053
K76.89
ICD-10 Finland
Other specified diseases of liver
151.9
28.7
30
*
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
+∞
28.2
27
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
28.0
626
3989
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
284.8
27.8
28
*
R18
ICD-10 Finland
Ascites
7.4
27.5
66
91
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.9
27.5
181
666
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.6
27.5
210
845
K83.1
ICD-10 Finland
Obstruction of bile duct
7.7
27.3
64
85
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
27.2
387
2098
K74.0
ICD-10 Finland
Hepatic fibrosis
+∞
27.1
26
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.3
26.9
139
434
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
4.1
26.4
105
263
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.2
25.7
101
250
JJ5AT
NOMESCO Finland
NA
94.5
25.7
28
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
7.1
25.2
62
89
A09AA02
ATC
multienzymes (lipase, protease etc.)
5.5
25.1
76
143
A02BC03
ATC
lansoprazole; oral
1.7
25.0
657
4372
A02BC01
ATC
omeprazole; systemic
1.7
25.0
615
4015
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
24.8
371
2046
B15.9
ICD-10 Finland
Hepatitis A without hepatic coma
91.1
24.7
27
*
N02AA05
ATC
oxycodone; systemic
2.1
24.6
324
1697
JN4BD
NOMESCO Finland
Extensive body CT
2.2
24.1
261
1255
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
23.9
565
3631
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
23.7
298
1531
A41.9
ICD-10 Finland
Sepsis, unspecified
3.7
23.5
105
292
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
4.1
23.3
93
234
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
3.2
23.0
125
405
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
23.0
485
3007
K92.0
ICD-10 Finland
Haematemesis
5.2
22.9
72
142
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
22.9
484
3005
A10AE04
ATC
insulin glargine; parenteral
2.3
22.6
225
1042
SPAT1262
SPAT
Handing over of treatment supplies
1.8
22.3
407
2406
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
52.5
22.1
26
5
J01FF01
ATC
clindamycin; systemic
1.7
21.9
598
3991
K70.0
ICD-10 Finland
Alcoholic fatty liver
63.1
21.9
25
*
B17.1
ICD-10 Finland
Acute hepatitis C
39.0
21.7
27
7
K76.80
ICD-10 Finland
Hepatic cyst
80.9
21.7
24
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
21.4
465
2902
WX892
NOMESCO Finland
Monitored bed care
2.4
21.4
185
795
WX002
NOMESCO Finland
Sedation and analgesia
1.8
21.3
436
2669
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
6.2
20.8
56
92
C07AA05
ATC
propranolol; systemic
1.8
20.8
431
2649
A02BC05
ATC
esomeprazole; systemic
1.5
20.5
879
6564
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
20.4
231
1132
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
20.3
250
1269
JJ1AT
NOMESCO Finland
Puncture of lesion of liver with ultrasound guidance
32.8
20.2
26
8
T90
ICPC
Diabetes non-insulin dependent
1.7
20.0
484
3110
XF600
NOMESCO Finland
Bloodpressure measurement
2.5
20.0
159
656
K72.1
ICD-10 Finland
Chronic hepatic failure
+∞
19.8
19
*
K71.9
ICD-10 Finland
Toxic liver disease, unspecified
+∞
19.8
19
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
19.6
508
3328
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
5.1
19.6
62
124
B16.9
ICD-10 Finland
Acute hepatitis B without delta-agent and without hepatic coma
105.9
19.6
21
*
B17.8
ICD-10 Finland
Other specified acute viral hepatitis
201.6
19.6
20
*
K70.4
ICD-10 Finland
Alcoholic hepatic failure
201.6
19.6
20
*
N05CF01
ATC
zopiclone; oral
1.6
19.2
694
4959
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
18.3
19.1
29
16
N05CD07
ATC
temazepam; oral
1.9
19.0
285
1563
K86.1
ICD-10 Finland
Other chronic pancreatitis
7.8
18.8
43
56
57309
ICD-8 Finland
Other diseases of liver, Unspecified
+∞
18.8
18
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
23.9
18.6
26
11
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
18.0
860
6529
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
18.0
270
1481
J01DB01
ATC
cefalexin; oral
1.6
18.0
1809
16089
C10AC01
ATC
colestyramine; oral
3.7
17.9
80
224
N06AB04
ATC
citalopram; systemic
1.7
17.9
462
3014
N05BA01
ATC
diazepam; systemic, rectal
1.9
17.8
298
1696
JJA20
NOMESCO Finland
Open biopsy of liver
20.2
17.7
26
13
K75.1
ICD-10 Finland
Phlebitis of portal vein
+∞
17.7
17
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
17.6
118
441
K81.0
ICD-10 Finland
Acute cholecystitis
4.7
17.4
59
128
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
6.7
17.4
44
67
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
7.1
17.3
42
60
SPAT1255
SPAT
Intravenous administration of medicine
2.4
17.3
157
693
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.8
17.3
57
120
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
17.2
208
1046
R4110
NOMESCO Finland
Physiotherapy
1.6
17.2
552
3809
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.8
17.2
113
417
N05AH04
ATC
quetiapine; oral
1.8
17.1
345
2091
JN4AD
NOMESCO Finland
Body CT examination
2.2
17.1
173
803
K85
ICD-10 Finland
Acute pancreatitis
5.0
16.9
54
110
R11
ICD-10 Finland
Nausea and vomiting
2.2
16.7
180
861
C07AB07
ATC
bisoprolol; oral
1.5
16.7
943
7381
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
35.3
16.7
21
6
A07AA11
ATC
rifaximin; oral
90.7
16.6
18
*
JJ4AT
NOMESCO Finland
Catherisation of liver lesion with ultrasound guidance
171.1
16.5
17
*
K50.8
ICD-10 Finland
Other Crohn disease
4.9
16.5
54
113
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
8.3
16.5
36
44
UJK12
NOMESCO Finland
Peroral cholangioscopy
18.0
16.5
25
14
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
16.4
602
4288
A41.8
ICD-10 Finland
Other specified sepsis
4.8
16.4
54
114
AA1AD
NOMESCO Finland
CT of head and brain
1.6
16.3
473
3176
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
14.4
16.3
27
19
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.1
16.2
88
287
3AC01
NOMESCO Finland
NA
6.9
16.2
40
59
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
6.6
16.1
41
63
WX402
NOMESCO Finland
General anaesthesia
1.7
16.1
354
2201
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.7
16.0
114
440
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
6.8
16.0
40
60
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.1
16.0
89
296
TK800
NOMESCO Finland
Hemodialysis
3.9
15.9
65
169
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.5
15.9
75
220
F10.24
ICD-10 Finland
Alcohol depence active use
5.4
15.9
47
88
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
15.7
254
1428
N07BB01
ATC
disulfiram; oral
2.7
15.6
109
418
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.6
15.6
115
454
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.7
15.6
69
193
R4190
NOMESCO Finland
Nutritional therapy
3.1
15.5
85
280
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
15.4
178
880
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.3
15.3
138
608
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.7
15.2
66
182
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.9
15.1
62
163
JKA20
NOMESCO Finland
Cholecystectomy
3.2
14.9
78
249
N03AE01
ATC
clonazepam; systemic
2.3
14.8
137
611
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
14.7
289
1732
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
14.6
689
5159
K73.89
ICD-10 Finland
Other long-term hepatitis, not classified differently
+∞
14.6
14
*
5720A
ICD-9 Finland
Liver abscess and sequelae of chronic liver disease, Abscess of liver
+∞
14.6
14
*
UJD02
NOMESCO Finland
Gastroscopy
2.5
14.5
116
481
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
14.5
189
982
H03AA01
ATC
levothyroxine sodium; systemic
1.6
14.5
488
3389
P01BA02
ATC
hydroxychloroquine; oral
2.0
14.4
185
954
R53
ICD-10 Finland
Malaise and fatigue
1.6
14.3
412
2751
K51.8
ICD-10 Finland
Other ulcerative colitis
5.0
14.3
45
91
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.6
14.3
102
398
B01AB05
ATC
enoxaparin; parenteral
1.5
14.2
615
4519
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.2
14.1
152
728
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.5
14.0
113
471
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
5.4
13.9
41
77
WX110
NOMESCO Finland
Local anesthesy
1.4
13.7
1450
12575
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
7.4
13.7
32
44
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
12.1
13.6
24
20
K71.0
ICD-10 Finland
Toxic liver disease with cholestasis
+∞
13.6
13
*
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
+∞
13.6
13
*
K50.9
ICD-10 Finland
Crohn disease, unspecified
4.7
13.5
45
97
F10.25
ICD-10 Finland
Alcohol dependence continuous use
4.2
13.4
50
121
N05BA04
ATC
oxazepam; oral
1.5
13.4
509
3628
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
13.9
13.2
22
16
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
4.5
13.2
46
104
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.4
13.1
46
105
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
5.0
13.1
41
83
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.0
13.0
169
874
K86.3
ICD-10 Finland
Pseudocyst of pancreas
8.3
13.0
28
34
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
13.0
341
2220
K50.1
ICD-10 Finland
Crohn disease of large intestine
4.9
12.9
41
84
R10.0
ICD-10 Finland
Acute abdomen
2.8
12.9
81
293
Z72.2
ICD-10 Finland
Drug use
11.6
12.8
23
20
C08CA01
ATC
amlodipine; oral
1.4
12.8
677
5164
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
12.8
266
1621
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
12.7
1056
8733
N03AX16
ATC
pregabalin; oral
1.5
12.7
485
3456
N03AX12
ATC
gabapentin; oral
1.6
12.6
320
2062
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
12.5
345
2275
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.4
12.3
108
472
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
12.3
126
592
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.1
12.3
144
717
WW500
NOMESCO Finland
Blood transfusion
2.6
12.2
89
352
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
12.1
158
820
L04AA01
ATC
[U] ciclosporin; systemic
4.1
12.1
46
114
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
8.7
12.0
25
29
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
10.1
12.0
23
23
A02BA02
ATC
ranitidine; systemic
1.5
12.0
390
2676
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
12.0
212
1230
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
11.8
246
1496
H02AB09
ATC
hydrocortisone; systemic
3.1
11.8
64
211
TKC20
NOMESCO Finland
Catheterisation of bladder
2.1
11.8
141
708
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.8
11.8
74
268
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
4.1
11.8
45
112
UJF92
NOMESCO Finland
Capsular endoscopy
3.2
11.7
60
190
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.2
11.6
118
552
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.6
11.6
81
314
N06AX11
ATC
mirtazapine; oral
1.4
11.6
639
4893
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
10.1
11.5
22
22
K73.8
ICD-10 Finland
Other chronic hepatitis, not elsewhere classified
+∞
11.5
11
*
57308
ICD-8 Finland
Other diseases of liver, Alii definiti
+∞
11.5
11
*
5714B
ICD-9 Finland
Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ACTIVA (HBSAG-)]
120.6
11.4
12
*
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
5.1
11.4
35
70
K50.0
ICD-10 Finland
Crohn disease of small intestine
3.8
11.3
47
126
L04AA05
ATC
[U] tacrolimus; systemic
35.2
11.3
14
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
8.9
11.2
23
26
K80.4
ICD-10 Finland
Calculus of bile duct with cholecystitis
5.0
11.2
35
71
K65.0
ICD-10 Finland
Acute peritonitis
5.1
11.2
34
67
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
11.2
109
502
K29.6
ICD-10 Finland
Other gastritis
5.7
11.2
31
55
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
6.8
11.1
27
40
K73.80
ICD-10 Finland
Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)
20.1
11.1
16
8
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
5.2
11.0
33
64
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
11.0
524
3896
WX872
NOMESCO Finland
Intensive care
2.2
10.9
106
486
P15
ICPC
Chronic alcohol abuse
3.0
10.9
62
210
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
10.9
156
840
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
12.0
10.8
19
16
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.6
10.8
77
303
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
10.8
215
1295
JLC30
NOMESCO Finland
Pancreatoduodenectomy
7.2
10.7
25
35
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
5.2
10.7
32
62
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
10.7
163
897
N30.0
ICD-10 Finland
Acute cystitis
1.6
10.7
267
1712
JN4CD
NOMESCO Finland
Very extensive body CT
2.4
10.6
89
381
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
8.5
10.5
22
26
A10BA02
ATC
metformin; oral
1.4
10.5
510
3803
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
6.6
10.5
26
40
L28
ICPC
Limited function/disability (L)
1.6
10.4
284
1863
K77.0*B25.1
ICD-10 Finland
Cytomegaloviral hepatitis
+∞
10.4
10
*
5719X
ICD-9 Finland
Chronic liver disease and cirrhosis, Unspecified chronic liver disease without mention of alcohol
+∞
10.4
10
*
K76.7
ICD-10 Finland
Hepatorenal syndrome
+∞
10.4
10
*
K86.01
ICD-10 Finland
Late effects of pancreatitis caused by alcohol
16.1
10.3
16
10
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
12.1
10.3
18
15
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
10.3
263
1696
N05BA12
ATC
alprazolam; oral
1.7
10.3
205
1232
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
10.2
408
2918
K81.9
ICD-10 Finland
Cholecystitis, unspecified
4.5
10.2
35
79
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
3.2
10.2
52
166
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
10.1
185
1080
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.2
10.1
104
492
JAH00
NOMESCO Finland
Laparotomy
2.7
10.1
65
241
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
7.9
10.1
22
28
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
7.9
10.1
22
28
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
7.9
10.1
22
28
J01MA14
ATC
moxifloxacin; systemic
1.8
10.1
179
1038
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.1
10.0
108
521
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
3.6
10.0
44
125
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
10.1
10.0
19
19
M04AA01
ATC
allopurinol; systemic
1.7
10.0
230
1440
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.3
10.0
87
381
S97
ICPC
Chronic ulcer skin
2.2
9.9
104
493
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.4
9.9
80
335
K30
ICD-10 Finland
Functional dyspepsia
1.7
9.9
218
1353
K80.1
ICD-10 Finland
Calculus of gallbladder with other cholecystitis
2.9
9.8
59
210
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
9.8
276
1823
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.7
9.8
64
240
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
9.8
150
830
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
8.8
9.8
20
23
E0000UV
ATC
NA
1.4
9.7
770
6234
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.0
9.7
131
689
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
7.4
9.7
22
30
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
5.1
9.7
29
57
JN1DM
NOMESCO Finland
Upper part of abdomen very extensive MRI examination with 3 Tesla magnet
55.2
9.6
11
*
R06.0
ICD-10 Finland
Dyspnoea
1.4
9.6
461
3424
SPAT1263
SPAT
Sampling
1.3
9.5
841
6919
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
15.1
9.5
15
10
J01DA01
ATC
[U] cefalexin; systemic
1.3
9.5
1303
11437
D02
ICPC
Abdominal pain epigastric
2.0
9.5
115
582
M79.6
ICD-10 Finland
Pain in limb
1.4
9.5
697
5574
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.4
9.5
80
343
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.5
9.5
43
126
UJF02
NOMESCO Finland
Peroral enteroscopy
6.2
9.4
24
39
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
12.4
9.4
16
13
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.6
9.3
64
247
E87.6
ICD-10 Finland
Hypokalaemia
2.7
9.3
61
230
N05AF03
ATC
chlorprothixene; systemic
2.7
9.2
62
236
A11CC03
ATC
alfacalcidol; systemic
3.0
9.2
50
168
TJK01
NOMESCO Finland
Laparoscopic cholangiography
4.8
9.1
29
61
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.7
9.1
59
220
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
6.3
9.1
23
37
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
3.5
9.1
41
120
XW000
NOMESCO Finland
Bone marrow biopsy
2.3
9.1
83
371
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
9.0
520
3986
K80.8
ICD-10 Finland
Other cholelithiasis
3.6
9.0
39
110
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
9.1
9.0
18
20
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
10.1
9.0
17
17
K02.1
ICD-10 Finland
Caries of dentine
1.3
9.0
1147
9927
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.1
9.0
48
159
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
4.9
9.0
28
58
M05BA04
ATC
alendronic acid; oral
1.8
8.9
155
891
A28
ICPC
Limited function/disability NOS
1.6
8.9
250
1649
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
24.1
8.9
12
5
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
8.0
8.8
19
24
B01AA03
ATC
warfarin; systemic
1.5
8.7
344
2450
A07AA09
ATC
vancomycin; oral
4.0
8.7
33
83
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
8.7
556
4334
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
8.7
184
1125
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.4
8.7
70
295
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
8.7
398
2920
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
8.7
172
1033
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
2.8
8.7
53
192
D13
ICPC
Jaundice
50.2
8.7
10
*
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
7.7
8.6
19
25
ZXA00
NOMESCO Finland
Right side
1.4
8.6
508
3905
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.7
8.6
188
1162
B27.0
ICD-10 Finland
Gammaherpesviral mononucleosis
6.2
8.6
22
36
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
6.2
8.6
22
36
P16
ICPC
Acute alcohol abuse
3.4
8.6
40
120
A10AE05
ATC
insulin detemir; parenteral
2.0
8.6
110
569
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.9
8.5
130
720
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
8.5
220
1422
P19
ICPC
Drug abuse
4.9
8.5
26
53
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
20.1
8.5
12
6
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.7
8.5
54
200
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
8.4
331
2356
R03AC02
ATC
salbutamol; inhalant
1.3
8.4
1034
8871
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
7.4
8.4
19
26
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
8.4
1100
9520
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.2
8.4
86
406
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
12.8
8.4
14
11
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.2
8.4
79
361
5714X
ICD-9 Finland
Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ALIA SEU NUD]
+∞
8.3
8
*
K70.2
ICD-10 Finland
Alcoholic fibrosis and sclerosis of liver
+∞
8.3
8
*
M25.5
ICD-10 Finland
Pain in joint
1.4
8.3
557
4371
J01EA01
ATC
trimethoprim; systemic
1.4
8.3
465
3544
D01
ICPC
Abdominal pain/cramps general
1.6
8.3
196
1239
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
8.3
413
3079
R60.0
ICD-10 Finland
Localized oedema
1.6
8.3
196
1240
N06AX16
ATC
venlafaxine; oral
1.5
8.3
265
1807
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
9.5
8.3
16
17
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
8.2
163
980
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
8.2
584
4624
ZXA10
NOMESCO Finland
Bilateral
1.5
8.2
344
2479
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
14.5
8.2
13
9
R06AE07
ATC
cetirizine; oral
1.3
8.2
861
7225
A40.8
ICD-10 Finland
Other streptococcal sepsis
4.9
8.2
25
51
SPAT1254
SPAT
Administration of medicine
1.5
8.2
258
1750
R51.80
ICD-10 Finland
Headache
1.5
8.2
274
1887
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.1
8.1
94
468
RS220
NOMESCO Finland
NA
4.0
8.1
31
79
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.7
8.1
175
1077
J01FA06
ATC
roxithromycin; oral
1.3
8.1
789
6549
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
17.2
8.1
12
7
M13.9
ICD-10 Finland
Arthritis, unspecified
1.8
8.1
137
786
C09AA05
ATC
ramipril; oral
1.4
8.1
438
3318
H02AB04
ATC
methylprednisolone; systemic
1.5
8.1
275
1898
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
8.1
149
876
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
22.1
8.0
11
5
N05CF02
ATC
zolpidem; oral
1.4
8.0
344
2495
L04AB04
ATC
adalimumab; parenteral
3.0
8.0
44
150
N06AB05
ATC
paroxetine; oral
1.8
7.9
122
678
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.7
7.8
32
87
S18
ICPC
Laceration/cut
1.3
7.8
794
6618
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
5.7
7.8
21
37
J02AC01
ATC
fluconazole; systemic
1.3
7.8
776
6452
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
4.7
7.8
25
54
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
10.8
7.8
14
13
B03BA03
ATC
hydroxocobalamin; parenteral
1.9
7.8
102
536
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.5
7.7
57
230
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
7.7
821
6888
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.6
7.6
32
89
N06AB03
ATC
fluoxetine; oral
1.5
7.6
243
1653
N05BA02
ATC
chlordiazepoxide; systemic
2.7
7.6
50
190
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
7.6
142
840
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.5
7.6
56
225
T89
ICPC
Diabetes insulin dependent
2.2
7.6
78
369
A04AA01
ATC
ondansetron; systemic, rectal
1.8
7.6
129
741
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
25.1
7.6
10
*
K90.0
ICD-10 Finland
Coeliac disease
2.4
7.6
62
264
N06AB10
ATC
escitalopram; oral
1.4
7.6
380
2837
A46
ICD-10 Finland
Erysipelas
1.5
7.5
252
1735
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.1
7.5
39
128
R42
ICD-10 Finland
Dizziness and giddiness
1.4
7.5
396
2977
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
7.1
7.5
17
24
N05AB01
ATC
dixyrazine; systemic
3.7
7.4
30
81
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.1
7.4
84
416
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.0
7.3
86
433
K86.8
ICD-10 Finland
Other specified diseases of pancreas
8.4
7.3
15
18
WZA90
NOMESCO Finland
Other doctors statement
1.4
7.3
437
3359
K92.1
ICD-10 Finland
Melaena
1.9
7.3
96
504
K73.1
ICD-10 Finland
Chronic lobular hepatitis, not elsewhere classified
+∞
7.3
7
*
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
10.9
7.3
13
12
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
10.9
7.3
13
12
F05.9
ICD-10 Finland
Delirium, unspecified
3.0
7.3
38
126
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.2
7.2
66
298
E83.1
ICD-10 Finland
Disorders of iron metabolism
5.8
7.2
19
33
NF1AA
NOMESCO Finland
Hip X-ray examination
1.7
7.2
151
923
D86.0
ICD-10 Finland
Sarcoidosis of lung
3.6
7.2
30
84
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.8
7.1
43
156
07009
ICD-8 Finland
Infectious hepatitis, Unspecified
20.1
7.1
10
5
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
7.1
766
6419
M05BA07
ATC
risedronic acid; oral
2.2
7.1
66
302
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
3.4
7.1
32
95
A03
ICPC
Fever
1.5
7.1
283
2021
A10BH01
ATC
sitagliptin; oral
1.6
7.1
168
1063
WX882
NOMESCO Finland
High dependency care
2.4
7.1
54
224
4AA12
NOMESCO Finland
NA
12.1
7.1
12
10
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
7.1
391
2964
M35.1
ICD-10 Finland
Other overlap syndromes
5.3
7.1
20
38
K85.2
ICD-10 Finland
Alcohol-induced acute pancreatitis
6.0
7.1
18
30
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.0
7.1
90
467
Z94.0
ICD-10 Finland
Kidney transplant status
3.9
7.1
27
70
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.7
7.0
133
791
E66.8
ICD-10 Finland
Other obesity
1.9
7.0
98
527
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.1
7.0
72
343
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
4.7
7.0
22
47
RD210
NOMESCO Finland
NA
2.8
7.0
42
152
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.8
7.0
42
152
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
1.9
7.0
92
485
B07.9
ICD-10 Finland
Verruca simplex
2.2
7.0
67
311
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.3
7.0
61
269
WX419
NOMESCO Finland
Other general anesthesy
3.6
7.0
29
81
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.9
7.0
40
139
ZXA05
NOMESCO Finland
Left side
1.3
6.9
468
3666
JFB00
NOMESCO Finland
Partial resection of small intestine
3.2
6.9
34
108
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.1
6.9
78
387
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.9
6.9
38
131
F11.1
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, harmful use
13.8
6.9
11
8
N17.8
ICD-10 Finland
Other acute renal failure
3.9
6.9
26
67
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
6.9
338
2512
R04.0
ICD-10 Finland
Epistaxis
1.8
6.8
119
690
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.5
6.8
252
1772
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.9
6.8
100
548
J01CA04
ATC
amoxicillin; systemic
1.3
6.8
1688
15652
J01CA08
ATC
pivmecillinam; oral
1.3
6.8
732
6128
SPAT1247
SPAT
Outpatient detoxication and monitoring
6.1
6.8
17
28
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
6.7
941
8133
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.9
6.7
99
544
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.8
6.7
112
641
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
22.6
6.7
9
*
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
6.7
89
471
X58
ICD-10 Finland
Exposure to other specified factors
1.5
6.7
247
1735
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
4.4
6.6
22
50
TQW80
NOMESCO Finland
Local dermatologic skincare
2.4
6.6
53
223
R74.9
ICD-10 Finland
Abnormal level of unspecified serum enzyme
5.2
6.6
19
37
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
6.6
1039
9104
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.4
6.6
29
85
N18.8
ICD-10 Finland
Other chronic renal failure
2.4
6.6
51
214
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
6.6
324
2408
D07AC01
ATC
betamethasone; topical
1.3
6.6
647
5345
R07.3
ICD-10 Finland
Other chest pain
1.6
6.6
172
1119
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
6.5
61
279
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
10.0
6.5
12
12
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.1
6.5
71
348
ZX108
NOMESCO Finland
Inhalation
4.8
6.5
20
42
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.7
6.5
116
678
R4120
NOMESCO Finland
Occupational therapy
1.7
6.5
116
679
K57.0
ICD-10 Finland
Diverticular disease of small intestine with perforation and abscess
5.0
6.5
19
38
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
6.5
131
794
M10.9
ICD-10 Finland
Gout, unspecified
1.8
6.4
110
635
B17.2
ICD-10 Finland
Acute hepatitis E
70.0
6.4
7
*
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
14.3
6.4
10
7
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
14.3
6.4
10
7
K07
ICPC
Swollen ankles/oedema
2.0
6.4
76
385
S22.3
ICD-10 Finland
Fracture of rib
1.8
6.3
111
646
WW200
NOMESCO Finland
Immunization
2.3
6.3
55
246
A01AB09
ATC
miconazole; local oral
1.6
6.3
160
1034
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
18.1
6.3
9
5
M01AB01
ATC
indometacin; systemic, rectal
1.7
6.3
129
786
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
6.3
313
2333
K74.2
ICD-10 Finland
Hepatic fibrosis with hepatic sclerosis
+∞
6.3
6
*
K76.6
ICD-10 Finland
Portal hypertension
+∞
6.3
6
*
K76.5
ICD-10 Finland
Hepatic veno-occlusive disease
+∞
6.3
6
*
D98
ICPC
Cholecystitis/cholelithiasis
4.3
6.2
21
49
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
6.2
441
3478
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
6.2
186
1248
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
6.2
202
1385
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.5
6.2
206
1416
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.2
6.2
57
262
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
3.4
6.1
27
80
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.2
6.1
58
267
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
4.2
6.1
21
50
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.3
6.1
53
236
J01AA02
ATC
doxycycline; systemic
1.3
6.1
1619
15006
120
Kela drug reimbursment
Hypogammaglobulinaemia
12.5
6.1
10
8
UKC02
NOMESCO Finland
Cystoscopy
1.4
6.1
271
1978
N19
ICD-10 Finland
Unspecified kidney failure
2.3
6.1
53
237
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.2
6.1
60
281
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
6.0
223
1569
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
2.5
6.0
43
172
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
6.0
52
229
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.4
6.0
46
190
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
6.0
457
3639
D09
ICPC
Nausea
2.0
6.0
69
345
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016650) Hepatitis A virus Ab [Presence] in Serum
316
269
13.26
317.26
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
247
84
32.44
307.65
1.1
1.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
621
354
22.86
307.65
1.7
1.2
titre
254.4
89.6
2.30
108
27
(3006922) Hepatitis E virus Ab [Presence] in Serum
268
86
34.70
307.65
1.2
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
846
1381
8.67
307.65
6.2
2.8
g/l
11.9
10.3
14.14
810
1261
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
247
84
32.44
307.65
1.1
1.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
896
1746
7.37
307.65
4.9
1.9
g/l
0.2
0.2
10.89
847
1643
(3028026) IgM [Mass/volume] in Serum or Plasma
683
1038
8.62
307.65
2.0
1.9
g/l
1.4
1.3
0.10
636
950
(40768441) Liver Pathology biopsy report
334
82
46.71
307.65
1.6
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
301
281
12.01
284.21
1.1
1.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
805
2176
4.94
282.26
6.5
2.5
umol/l
16.8
7.3
11.74
730
1892
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1529
6642
4.25
281.56
9.2
2.9
u/l
54.7
32.4
13.03
1466
6314
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1920
10607
4.27
232.36
14.9
5.8
umol/l
15.6
10.9
13.75
1857
10041
(3037522) Nuclear Ab [Titer] in Serum
835
2670
4.16
229.50
1.9
1.3
titre
695.7
482.8
2.75
286
543
(3023183) Ammonium ion [Moles/volume] in Plasma
278
317
9.72
226.74
4.6
1.9
umol/l
37.4
31.1
3.19
242
268
(3024561) Albumin [Mass/volume] in Serum or Plasma
1694
8751
3.78
223.24
10.2
4.5
g/l
34.6
35.7
12.48
1614
8147
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
300
388
8.63
221.37
4.8
5.3
iu/ml
857.0
325.4
0.99
36
53
(3017143) Hepatitis C virus Ab [Presence] in Serum
726
2200
4.21
213.20
1.6
1.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
251
278
9.90
208.95
1.9
1.6
g/l
0.8
0.8
0.17
186
205
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
278
366
8.40
201.73
1.2
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
212
194
11.83
201.71
1.1
1.1
g/l
1.6
1.5
2.47
194
177
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
179
124
15.45
201.30
1.6
1.2
titre
267.7
85.2
3.02
62
23
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
263
348
8.31
189.81
1.2
1.2
u/ml
307.2
242.1
2.04
161
214
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
270
382
7.78
183.86
1.2
1.5
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
154
98
16.66
180.95
1.1
1.0
mg/l
300.0
290.0
0.52
144
90
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
265
387
7.52
175.28
1.2
1.4
u/ml
16.9
16.4
—
7
8
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
239
310
8.40
175.13
2.3
2.9
u/ml
451.6
2054.6
0.78
18
22
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
786
2852
3.54
173.10
1.6
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
172
149
12.30
169.22
1.1
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
319
592
6.01
167.08
1.3
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1276
6308
3.05
164.50
4.7
2.4
u/l
56.9
57.4
0.12
1211
5819
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
244
352
7.56
162.94
1.3
1.5
u/ml
111.3
120.7
0.31
38
67
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
718
2555
3.52
161.75
2.7
2.5
%
26.2
22.8
4.59
628
2176
(3032080) INR in Blood by Coagulation assay
1477
8061
2.98
156.41
12.2
8.7
inr
1.2
1.2
3.78
457
2339
(3007164) IgA [Mass/volume] in Serum or Plasma
918
3892
3.12
153.49
2.0
1.4
g/l
2.7
2.3
5.52
709
2327
(42870588) Differential panel, method unspecified - Blood
1336
6982
2.92
152.10
10.6
5.9
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
736
2760
3.34
151.24
2.7
2.4
g/l
2.4
2.3
0.40
698
2556
(3033658) Prothrombin time (PT) actual/Normal
1097
5190
2.95
149.86
10.6
3.6
%
87.3
91.3
5.48
1070
5052
(3022948) Iron [Moles/volume] in Serum or Plasma
764
3013
3.19
143.34
2.8
2.4
umol/l
14.4
13.2
3.22
731
2785
(3022096) Basophils/100 leukocytes in Blood
1583
9421
2.79
134.51
11.9
6.0
%
0.7
0.7
2.23
1530
8794
(3019069) Monocytes/100 leukocytes in Blood
1616
9748
2.79
133.19
12.1
6.3
%
8.8
8.6
1.75
1561
9125
(3006315) Basophils [#/volume] in Blood
1684
10380
2.83
132.92
11.7
5.8
e9/l
0.0
0.0
0.44
1521
8995
(3001604) Monocytes [#/volume] in Blood
1678
10342
2.82
132.14
11.6
5.8
e9/l
0.6
0.6
0.11
1520
8958
(3006504) Eosinophils/100 leukocytes in Blood
1607
9696
2.77
131.85
11.8
6.0
%
2.8
2.8
0.01
1552
9030
(3002030) Lymphocytes/100 leukocytes in Blood
1632
10026
2.74
127.39
11.9
6.0
%
27.4
28.1
1.79
1573
9352
(3019198) Lymphocytes [#/volume] in Blood
1699
10654
2.78
127.22
11.7
5.9
e9/l
1.8
2.0
1.15
1552
9415
(3018010) Neutrophils/100 leukocytes in Blood
1611
9877
2.71
125.49
11.6
5.8
%
57.6
57.1
0.96
1551
9250
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
105
65
16.80
124.75
1.5
1.6
iu/ml
1118200.0
2284600.0
—
7
5
(3013115) Eosinophils [#/volume] in Blood
1702
10747
2.75
124.52
12.1
6.1
e9/l
0.2
0.2
1.43
1565
9452
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2185
16015
3.53
116.67
19.6
7.1
u/l
102.6
76.6
45.71
2114
15066
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
524
1911
3.19
109.27
4.3
2.3
u/l
122.2
39.2
0.46
463
1653
(3013650) Neutrophils [#/volume] in Blood by Automated count
1796
12084
2.64
108.02
15.8
9.1
e9/l
4.0
4.1
0.33
1645
10577
(3021879) Hepatitis B virus core Ab [Presence] in Serum
441
1486
3.38
104.46
1.4
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1023
5381
2.50
104.45
6.6
4.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
279
685
4.45
104.23
3.8
3.6
u/ml
424.3
5974.4
0.77
244
585
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
245
568
4.66
98.26
1.3
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
1071
6036
2.33
90.53
5.2
4.0
ph
7.4
7.4
0.36
204
1142
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1919
13865
2.55
90.27
8.0
2.9
u/l
107.6
45.4
35.72
1815
12931
(3003458) Phosphate [Moles/volume] in Serum or Plasma
599
2614
2.69
88.07
6.7
5.7
mmol/l
1.1
1.0
0.88
569
2423
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1533
10163
2.27
86.13
9.3
6.6
mmol/l
1.2
1.2
2.39
1309
8574
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1431
9224
2.25
86.12
8.3
6.0
mmol/l
1.2
1.2
2.56
1351
8349
(3020779) Urea [Moles/volume] in Serum or Plasma
454
1732
2.97
85.97
9.8
7.2
mmol/l
9.0
9.4
0.47
433
1655
(3018677) aPTT in Platelet poor plasma by Coagulation assay
659
3063
2.55
84.77
2.4
2.1
s
30.4
29.6
3.03
639
2965
(3012095) Magnesium [Moles/volume] in Serum or Plasma
691
3289
2.51
84.46
4.8
3.3
mmol/l
0.8
0.8
11.15
657
3092
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
94
95
10.23
82.89
4.1
1.5
%
85.8
102.8
3.38
94
89
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
558
2428
2.66
81.92
2.2
1.8
%
1.6
1.5
2.52
485
2151
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1342
8599
2.18
79.75
3.4
2.2
nmol/l
76.3
77.4
0.70
1248
7752
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
514
2197
2.68
77.85
3.9
4.3
u/l
254.0
243.7
0.67
484
2080
(3042936) Bacteria identified in Isolate by Culture
620
2901
2.50
77.83
2.6
2.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
77
65
12.18
76.56
3.9
2.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
56
27
21.18
74.36
2.3
1.3
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
83
82
10.43
74.33
32.1
31.2
ug/l
6.7
7.7
1.60
78
74
(4062490)
118
181
6.79
73.80
1.3
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
146
283
5.41
71.88
1.3
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1676
12077
2.13
69.01
7.7
4.7
mmol/l
6.9
6.7
2.46
1600
11288
(3024139) IgG subclass 3 [Mass/volume] in Serum
113
178
6.60
68.88
1.3
1.4
g/l
0.5
0.3
3.32
67
122
(3028192) IgG subclass 2 [Mass/volume] in Serum
113
178
6.60
68.88
1.3
1.4
g/l
3.1
3.0
0.23
66
121
(3027135) IgG subclass 1 [Mass/volume] in Serum
113
178
6.60
68.88
1.3
1.4
g/l
9.0
6.4
3.78
67
122
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
465
2005
2.61
68.48
4.2
4.2
ug/l
7.5
24.2
2.33
374
1625
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
192
502
4.05
65.33
2.1
1.3
iu/ml
25.5
11.9
—
10
10
(3009445) Proteinase 3 Ab [Units/volume] in Serum
257
832
3.32
63.58
1.7
1.5
u/ml
4.6
22.3
1.28
18
21
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
104
166
6.49
62.56
1.9
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1313
8868
1.99
61.91
4.0
2.7
ug/l
222.6
120.7
6.09
1252
8192
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
160
383
4.39
61.16
4.5
3.5
u/ml
270.9
1042.8
0.59
142
358
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
109
187
6.04
61.03
1.2
1.1
u/l
49.6
56.0
0.53
84
133
(3013707) Erythrocyte sedimentation rate by Westergren method
1971
15464
2.21
60.36
6.7
4.0
mm/h
16.2
11.8
24.09
1864
14334
(3002582) Erythrocytes [#/volume] in Urine
994
6145
2.01
59.86
4.2
3.2
e6/l
31.6
80.5
2.77
795
4704
(36304419) Bacteria [Presence] in Urine
915
5507
2.03
59.29
4.0
3.0
—
—
—
0
0
(3026782) Osmolality of Urine
718
3957
2.13
58.98
3.5
2.7
mosm/kgh2o
521.9
550.5
2.82
627
3361
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
156
377
4.34
58.88
1.1
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
351
1416
2.71
58.49
2.0
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
787
4503
2.08
58.43
1.4
1.3
u/ml
1.1
1.6
1.00
178
1213
(4035726)
409
1787
2.53
57.91
1.5
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1785
13588
2.04
57.82
5.7
4.4
e6/l
355.8
1779.9
1.81
26
195
(3030467) Casts [#/volume] in Urine by Automated count
926
5636
2.01
57.82
4.1
3.1
e6/l
0.4
0.4
0.18
733
4240
(3010375) cycloSPORINE [Mass/volume] in Blood
73
86
8.71
57.29
31.1
24.1
ug/l
119.4
118.7
0.03
61
67
(44816559) Phosphatidylethanol [Mass/volume] in Blood
147
347
4.43
57.17
1.5
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
857
5101
2.02
56.77
3.1
2.1
mg/l
3.1
2.9
1.51
765
4334
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
213
662
3.42
56.07
1.8
1.6
titre
218.2
336.9
0.35
11
26
(40758558) Short blood count panel - Blood
883
5335
2.00
55.89
11.4
6.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1333
9261
1.92
55.62
18.1
9.3
e9/l
0.0
0.0
0.39
1133
7591
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
81
118
7.06
53.07
1.4
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
189
564
3.54
52.94
5.1
3.6
mg/l
1.6
1.5
0.33
179
524
(3000850) Epithelial cells [#/volume] in Urine
743
4290
2.03
52.91
3.4
2.6
e6/l
7.6
5.8
1.70
658
3754
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
77
107
7.39
52.63
1.2
1.1
u/l
99.7
76.9
1.08
71
91
(3018095) Leukocytes [#/volume] in Urine
1095
7231
1.90
52.38
4.8
3.7
e6/l
86.0
94.0
0.11
837
5082
(46235355) HIV 1 and 2 tests - Meaningful Use set
649
3592
2.08
51.72
1.9
1.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
454
2203
2.29
50.33
3.0
2.7
%
1.9
1.8
2.47
414
1972
(3044640) Blood type and Crossmatch panel - Blood
1004
6525
1.89
49.78
3.6
2.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
74
106
7.16
49.22
1.2
1.1
u/l
23.5
15.0
0.62
68
89
(3036481) Cortisol [Moles/volume] in Serum or Plasma
406
1896
2.36
49.13
2.8
2.1
nmol/l
344.7
374.8
2.45
382
1730
(3037467) Urinalysis macro (dipstick) panel - Urine
1815
14297
1.93
48.04
5.6
4.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
486
2503
2.16
46.20
20.2
24.5
inr
1.3
1.3
0.34
79
360
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
588
3256
2.05
46.11
2.1
1.8
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
229
848
2.87
44.50
1.7
1.9
g/l
1.4
1.6
1.56
197
745
(3002179) Metamyelocytes/100 leukocytes in Blood
344
1557
2.40
44.42
4.8
3.8
%
0.4
0.5
0.65
103
342
(3048689) Calprotectin [Mass/mass] in Stool
477
2491
2.12
43.51
3.4
2.3
ug/g
167.5
130.5
1.39
409
1966
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
77
131
6.03
43.45
1.1
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
40
29
13.99
43.38
2.2
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
483
2541
2.11
43.19
9.5
7.1
mmol/l
104.1
104.4
0.58
471
2486
(3017181) Myelocytes/100 leukocytes in Blood
363
1720
2.29
42.06
5.0
4.0
%
0.6
0.9
1.62
130
475
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
237
926
2.72
41.53
4.4
4.3
mmol/l
24.0
24.1
0.17
226
837
(3002032) Base excess in Venous blood by calculation
371
1791
2.25
41.06
4.0
3.7
mmol/l
1.6
1.9
0.88
298
1452
(3023520) Reticulocytes [#/volume] in Blood
344
1615
2.31
40.66
2.6
2.7
e9/l
72.5
70.0
0.56
262
1236
(3021447) Carbon dioxide [Partial pressure] in Venous blood
372
1807
2.24
40.52
4.0
3.7
kpa
5.7
5.9
2.00
357
1755
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
441
2297
2.11
40.24
2.0
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1318
9751
1.73
39.15
5.5
3.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
135
396
3.54
38.71
1.5
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
558
3211
1.94
38.37
3.3
2.9
e6/l
2.7
2.4
0.31
315
1730
(3000570) Elastase.pancreatic [Mass/mass] in Stool
172
594
3.03
37.79
1.5
1.4
ug/g
222.0
289.0
3.51
111
348
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
168
585
3.00
36.37
2.2
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
336
1635
2.21
36.22
5.1
4.0
%
0.1
0.1
1.15
121
438
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
168
589
2.98
35.93
3.4
2.5
g/l
3.2
3.7
3.27
160
557
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
425
2279
2.04
35.51
2.0
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
319
1537
2.23
35.19
5.3
4.1
%
0.0
0.5
0.98
106
365
(3023487) Leukocytes [#/volume] in Peritoneal fluid
39
38
10.41
35.14
2.7
1.8
e6/l
18892.0
1186.6
0.46
29
30
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
64
112
5.83
35.09
1.7
1.5
u/l
7.7
7.6
0.01
42
53
(3000991) Gas panel - Venous blood
336
1659
2.18
34.86
10.3
8.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
575
3444
1.86
34.55
3.1
2.7
e6/l
1.3
1.1
0.45
328
1952
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
636
3936
1.82
34.36
4.3
3.6
ng/l
334.8
425.3
0.32
486
3013
(3044007) Cell count panel - Peritoneal fluid
37
35
10.71
34.01
2.0
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
878
6005
1.70
33.22
3.6
3.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
346
1767
2.11
32.81
8.8
7.4
mmol/l
1.5
1.3
1.06
330
1700
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
757
5000
1.73
32.36
3.7
2.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
74
160
4.73
32.06
2.8
1.4
g/l
0.9
0.9
0.27
74
160
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
165
627
2.74
30.37
2.1
1.8
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
35
36
9.84
30.34
2.6
1.4
e6/l
875.7
4496.4
1.19
22
21
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1124
8341
1.62
30.11
2.3
1.9
pmol/l
95.8
95.4
0.08
610
4316
(40768797) Stomach Pathology biopsy report
484
2855
1.86
30.07
1.3
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
157
585
2.79
29.99
2.1
1.6
g/l
0.2
0.2
3.29
146
553
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
161
609
2.75
29.89
2.1
1.6
g/l
1.2
1.2
0.07
150
576
(3020630) Protein [Mass/volume] in Serum or Plasma
313
1599
2.09
29.51
2.4
2.8
g/l
66.6
66.3
0.15
282
1460
(3021960) Folate [Moles/volume] in Serum or Plasma
707
4685
1.70
29.36
1.7
1.5
nmol/l
19.8
20.7
0.86
632
4006
(3026692) Albumin [Mass/volume] in Peritoneal fluid
31
28
11.19
29.35
1.9
1.1
g/l
9.6
15.2
1.70
19
21
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
188
779
2.53
29.06
2.2
2.0
ug/l
2.8
1.7
0.67
170
695
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
53
94
5.74
28.67
2.9
2.6
u/ml
1633.2
1281.1
0.33
53
94
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
48
78
6.25
28.36
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
67
148
4.62
28.29
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
67
148
4.62
28.29
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
67
148
4.62
28.29
1.3
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
967
6996
1.62
28.23
3.7
3.4
mmol/l
2.3
2.4
2.56
874
6151
(40759836) Histone Ab [Presence] in Serum by Immunoblot
66
145
4.65
28.06
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
66
145
4.65
28.06
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
66
145
4.65
28.06
1.3
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
162
635
2.66
28.04
2.5
2.8
u/ml
0.3
0.3
0.77
93
354
(3027801) Oxygen [Partial pressure] in Arterial blood
406
2313
1.90
27.95
9.5
7.7
kpa
12.0
12.4
0.91
385
2214
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
406
2313
1.90
27.95
9.5
7.7
kpa
5.0
5.1
2.40
383
2213
(3034274) Bile acid [Moles/volume] in Serum --fasting
80
206
3.98
27.70
2.9
2.1
umol/l
13.5
4.9
3.15
61
138
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
144
540
2.77
27.17
1.4
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
690
4622
1.68
27.16
7.6
4.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
401
2305
1.88
26.77
9.6
7.7
mmol/l
1.0
1.1
0.16
305
1806
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
120
411
3.01
26.72
1.5
1.2
u/ml
21.0
4.9
0.35
11
28
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
162
651
2.59
26.66
1.7
1.6
iu/ml
0.6
9.9
0.47
41
124
(3052851) Hemolysis interference index of Serum or Plasma
152
592
2.67
26.64
3.7
3.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
411
2389
1.86
26.47
1.9
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1297
10155
1.56
26.38
4.4
3.6
estimate
0.0
0.0
0.80
289
1889
(3042733) HLA Ab [Presence] in Serum
41
61
6.81
26.34
2.6
5.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2317
21026
2.11
26.32
28.9
13.5
mg/l
23.9
23.7
0.12
2096
16470
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
864
6168
1.61
26.18
2.6
2.1
u/l
188.9
234.4
0.84
816
5790
(3021601) Nitrite [Presence] in Urine by Test strip
1297
10180
1.56
25.92
5.7
4.8
estimate
0.0
0.0
0.50
295
1927
(3009261) Glucose [Presence] in Urine by Test strip
1307
10288
1.55
25.70
4.4
3.6
estimate
0.0
0.0
1.08
279
1850
(3026493) Urate [Moles/volume] in Serum or Plasma
775
5415
1.62
25.53
3.5
2.6
umol/l
1353.4
5367.0
4.53
678
4704
(3030905) Polymorphonuclear cells [#/volume] in Blood
113
385
3.02
25.39
4.7
3.4
e9/l
3.9
4.1
0.72
113
385
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
44
76
5.87
24.47
1.3
3.6
umol/l
49.4
131.8
2.36
11
48
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
114
399
2.94
24.43
5.1
3.6
%
56.5
57.3
0.28
114
399
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
288
1529
2.00
24.24
3.8
3.8
ng/l
92.4
89.4
0.25
253
1326
(3015171) Extractable nuclear Ab [Units/volume] in Serum
176
770
2.38
24.13
1.4
1.2
u/ml
1.7
1.1
0.16
11
68
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
41
67
6.20
24.10
1.0
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
359
2071
1.85
23.51
10.3
8.1
%
95.7
95.7
0.04
344
2000
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
135
531
2.63
23.20
1.5
1.2
u/ml
14.4
9.8
0.31
24
87
(3002173) Hemoglobin [Mass/volume] in Arterial blood
338
1929
1.87
22.86
10.7
8.6
g/l
116.7
122.1
4.61
324
1858
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
117
433
2.78
22.64
1.4
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
38
63
6.11
22.03
1.1
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
139
570
2.52
21.93
1.5
1.2
u/ml
44.7
32.3
0.24
12
29
(3024354) Oxygen [Partial pressure] in Venous blood
274
1480
1.95
21.86
3.4
3.0
kpa
4.7
4.6
0.55
260
1434
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
131
524
2.58
21.76
1.5
1.2
u/ml
8.6
2.6
0.63
20
47
(36660697) Celiac disease serology panel - Serum
290
1604
1.91
21.55
1.2
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
38
65
5.92
21.35
1.0
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
149
641
2.41
21.20
2.6
2.3
%
80.3
91.8
4.51
143
603
(3019309) Folate [Moles/volume] in Red Blood Cells
548
3657
1.63
21.13
1.8
1.7
nmol/l
1179.0
1180.9
0.02
441
2771
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1007
7721
1.50
20.89
4.3
3.5
ng/l
118.9
51.1
0.55
711
5162
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
184
873
2.19
20.81
2.0
1.9
u/l
44.2
38.8
2.48
167
779
(3039162) Centromere protein B Ab [Units/volume] in Serum
80
251
3.26
20.68
1.6
1.2
u/ml
57.9
61.8
—
6
12
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
652
4562
1.58
20.56
2.1
1.7
mg/l
1.6
1.1
3.50
525
3463
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
35
58
6.10
20.30
1.7
1.4
ug/l
11.0
8.2
2.07
35
58
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
110
424
2.67
19.70
1.6
1.2
u/ml
42.5
46.4
0.10
13
42
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
22
22
10.08
19.38
1.2
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
224
1176
1.99
19.35
1.8
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
229
1214
1.97
19.23
4.4
3.5
ph
7.4
7.4
1.68
34
147
(3009508) Creatinine [Moles/volume] in Urine
859
6471
1.49
18.95
3.9
3.2
mmol/l
6.9
7.6
5.09
704
5448
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
94
342
2.81
18.81
1.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1074
8473
1.46
18.66
2.2
2.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
373
2326
1.71
18.45
1.7
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
229
1232
1.94
18.41
4.5
3.5
kpa
5.2
5.2
0.40
211
1151
(3000494) Fungus identified in Specimen by Culture
390
2472
1.68
18.14
1.7
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
128
552
2.39
18.13
2.2
2.0
mg/l
12.1
11.4
0.38
119
508
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
70
221
3.23
17.95
2.3
2.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
67
207
3.30
17.79
1.1
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
242
1341
1.89
17.79
1.8
2.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
218
1171
1.94
17.60
4.5
3.5
mmol/l
1.9
1.8
0.19
162
882
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
208
1101
1.97
17.53
11.9
10.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
341
2112
1.71
17.23
4.7
3.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1968
17599
1.52
16.77
34.9
16.5
%
14.1
13.6
21.30
1945
17206
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
130
587
2.28
16.58
2.7
2.5
%
215.5
186.8
2.72
123
559
(3003327) Ova and parasites identified in Stool by Light microscopy
141
663
2.19
16.31
1.8
1.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
195
1040
1.95
16.06
13.0
10.4
mmol/l
24.2
24.3
0.26
183
984
(3019550) Sodium [Moles/volume] in Serum or Plasma
2318
21629
1.78
15.70
30.2
15.4
mmol/l
139.1
139.7
23.18
2289
21099
(3003181) Sodium [Moles/volume] in Urine
88
341
2.64
15.64
1.7
1.3
mmol/l
57.4
64.8
1.01
71
274
(3023103) Potassium [Moles/volume] in Serum or Plasma
2322
21688
1.78
15.53
30.4
15.5
mmol/l
3.9
4.0
3.89
2292
21126
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
274
1648
1.74
15.32
3.5
2.7
ng/l
254.0
188.9
0.80
237
1484
(3036489) Thrombin time
153
770
2.05
14.85
2.5
2.1
s
22.7
21.3
1.71
141
684
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
115
528
2.23
14.13
1.8
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
228
1332
1.78
14.08
5.7
5.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
639
4766
1.45
14.01
4.1
3.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
132
644
2.11
13.92
2.5
2.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
148
755
2.02
13.85
1.7
2.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
148
755
2.02
13.85
1.7
2.7
g/l
7.8
7.3
1.54
103
578
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
88
365
2.46
13.63
1.1
1.2
—
380.0
—
0
8
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
62
216
2.92
13.51
1.1
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
204
1173
1.80
13.28
1.6
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
110
509
2.21
13.27
1.9
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
146
755
1.99
13.16
1.7
2.7
g/l
3.9
3.8
0.35
101
551
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
20
29
6.94
13.14
1.1
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
97
428
2.32
13.11
5.3
3.9
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
43
122
3.57
13.09
1.4
1.2
mmol/l
30.6
34.3
0.56
37
107
(3004809) Band form neutrophils/100 leukocytes in Blood
77
306
2.56
13.06
2.8
3.5
%
1.1
1.4
0.65
67
245
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1804
16137
1.40
13.02
4.7
4.0
pmol/l
15.0
14.8
3.65
1666
14718
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
522
3795
1.47
12.94
3.5
3.1
mmol/l
2.5
2.4
3.15
450
3364
(3020191) Ethanol [Moles/volume] in Serum or Plasma
48
148
3.29
12.86
2.1
1.4
promille
1.3
1.3
0.01
37
111
(3008152) Bicarbonate [Moles/volume] in Arterial blood
215
1270
1.76
12.77
7.9
7.0
mmol/l
23.9
24.6
1.51
200
1183
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
139
715
2.00
12.72
1.7
2.7
g/l
3.3
3.1
1.53
102
567
(3011412) CD3 cells [#/volume] in Blood
55
186
3.00
12.65
2.6
2.4
e9/l
1.1
1.1
0.03
33
113
(3025941) Bacteria identified in Stool by Culture
198
1147
1.79
12.57
1.4
1.2
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
36
93
3.91
12.53
1.2
1.1
u/l
27.9
21.9
0.42
30
69
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
95
424
2.29
12.51
1.4
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
48
151
3.22
12.47
2.5
2.3
e6/l
554.4
693.4
0.77
20
59
(3012501) Base excess in Blood by calculation
98
446
2.24
12.33
5.9
4.5
mmol/l
2.6
2.6
0.03
76
301
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
128
648
2.03
12.25
1.9
2.8
g/l
0.6
1.1
0.81
104
573
(3012516) Albumin [Mass/volume] in Urine
767
6040
1.39
12.06
3.8
3.3
mg/l
509.3
372.2
0.33
495
3798
(3029937) Albumin [Presence] in Urine by Test strip
705
5475
1.40
12.05
5.2
4.0
estimate
0.0
0.0
0.28
276
1860
(3000093) Morphology [Interpretation] in Blood Narrative
51
170
3.04
12.04
1.0
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
117
577
2.08
12.03
1.7
2.6
g/l
0.0
0.0
0.26
103
533
(3047181) Lactate [Moles/volume] in Blood
126
639
2.02
12.01
6.2
6.7
mmol/l
1.3
1.3
0.04
104
560
(3028626) Oxygen [Partial pressure] in Capillary blood
97
445
2.23
11.98
3.8
3.1
kpa
8.4
8.2
0.82
87
410
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
135
703
1.97
11.94
1.8
2.7
g/l
12.9
10.0
4.65
109
602
(3014007) Fractional oxyhemoglobin in Arterial blood
216
1302
1.72
11.94
13.4
9.5
%
93.6
93.9
0.22
216
1294
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
35
92
3.84
11.91
1.2
1.1
u/l
102.6
73.0
1.43
30
73
(21494815) CD4 cells/100 lymphocytes in Specimen
50
166
3.05
11.89
2.7
2.2
%
43.1
46.5
—
8
20
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
85
370
2.34
11.87
1.9
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
103
488
2.16
11.75
3.4
3.0
mmol/l
24.9
25.0
0.09
90
423
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
260
1655
1.64
11.69
5.3
3.8
mmol/l
1.2
1.2
1.49
240
1428
(3022313) Gas panel - Capillary blood
159
883
1.85
11.60
4.6
3.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
955
7829
1.35
11.52
4.8
3.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
706
5527
1.38
11.38
4.1
3.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
93
429
2.21
11.35
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
93
429
2.21
11.35
1.4
1.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
213
1298
1.70
11.31
13.2
9.4
%
0.6
0.7
0.46
213
1291
(4281824)
54
193
2.84
11.29
1.3
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
40
122
3.31
10.95
4.8
3.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2079
19253
1.43
10.84
5.7
4.7
mu/l
2.0
2.1
0.47
1946
17680
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
27
63
4.32
10.76
1.0
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
25
55
4.58
10.71
2.4
3.3
au/ml
158.4
32.9
—
5
10
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
720
5702
1.37
10.69
3.5
2.9
ng/l
1713.9
1327.1
1.04
610
4829
(3020682) Albumin/Creatinine [Ratio] in Urine
789
6339
1.35
10.67
4.7
4.0
mg/mmol
13.2
8.4
1.17
482
3987
(3037121) Protein [Mass/volume] in Urine
132
712
1.90
10.55
3.9
3.1
g/l
0.3
0.3
0.58
73
288
(3010421) pH of Blood
107
539
2.03
10.42
5.9
4.2
ph
7.4
7.4
1.34
95
442
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
15
8
18.85
10.25
1.7
2.6
mg/l
2.7
3.9
—
15
8
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
11
10
11.04
10.16
4.3
2.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
27
66
4.12
10.15
1.0
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
106
539
2.01
10.07
1.7
2.7
g/l
0.0
0.0
0.00
94
496
(40767503) Oxygen content in Capillary blood by calculation
87
411
2.16
10.05
3.7
2.5
%
15.6
16.4
0.98
44
208
(3029075) Extractable nuclear Ab panel - Serum
25
58
4.34
10.04
1.2
1.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
114
596
1.96
10.01
1.7
2.5
g/l
35.3
37.8
3.36
94
520
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
105
534
2.01
9.98
1.7
2.7
g/l
0.0
0.0
0.00
94
495
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
42
142
2.99
9.73
2.3
2.3
%
11.4
13.3
0.40
21
64
(1175426) CD3 cells/100 lymphocytes in Blood
42
143
2.97
9.62
2.3
2.4
%
73.6
73.2
0.07
42
136
(3051611) Lipemic interference index of Serum or Plasma
53
205
2.62
9.58
4.4
3.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
16
26
6.19
9.45
1.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
85
408
2.12
9.44
1.3
1.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
142
813
1.79
9.42
5.6
5.6
%
1.9
1.6
1.37
130
758
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
114
610
1.91
9.37
1.2
1.3
miu/ml
212.9
214.0
0.01
41
272
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
258
1728
1.55
9.33
2.6
2.4
ug/l
6.9
7.4
0.18
223
1546
(3017732) Neutrophils [#/volume] in Blood
224
1454
1.59
9.28
3.1
3.2
e9/l
4.3
4.1
0.51
180
1149
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
13
17
7.68
9.27
1.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
13
17
7.68
9.27
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
264
1781
1.54
9.24
5.3
3.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
54
215
2.54
9.22
2.8
3.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
40
136
2.97
9.19
2.1
2.3
—
—
—
0
0
(44790048)
61
260
2.38
9.01
1.6
1.5
—
—
—
0
0
(44790047)
61
260
2.38
9.01
1.6
1.5
—
—
—
0
0
(44806118)
61
260
2.38
9.01
1.6
1.5
—
—
—
0
0
(44790049)
61
260
2.38
9.01
1.6
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
75
351
2.17
8.90
3.5
2.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
103
546
1.92
8.73
1.1
1.1
u/ml
5.3
5.2
—
6
68
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
25
65
3.87
8.68
3.0
3.7
mg/l
5.9
7.0
0.36
18
57
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
251
1699
1.53
8.64
3.4
2.6
ml/min/173m2
64.6
67.4
0.46
105
659
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
553
4324
1.36
8.64
1.7
1.7
pmol/l
455.3
33989896.6
3.93
449
3607
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
86
431
2.03
8.55
1.7
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2351
22505
1.56
8.45
24.3
10.0
u/l
41.2
26.2
20.46
2313
21741
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2115
19866
1.38
8.28
25.2
12.5
ml/min/173m2
83.0
81.8
1.55
1850
16341
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
31
98
3.19
8.08
1.2
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
31
98
3.19
8.08
1.2
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
57
248
2.33
8.08
1.6
1.5
—
—
—
0
0
(4198724)
26
74
3.54
7.97
2.0
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
108
600
1.84
7.95
1.9
3.9
mg/l
47.6
65.9
0.70
88
485
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
49
201
2.47
7.91
3.0
4.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
130
768
1.73
7.78
5.2
3.8
mmol/l
24.9
25.0
0.11
125
718
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
46
187
2.49
7.58
2.5
2.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
10
12
8.36
7.58
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
49
206
2.41
7.52
1.1
1.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2342
22473
1.51
7.50
32.1
15.6
umol/l
78.4
76.6
1.59
2342
22466
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
104
582
1.82
7.49
1.9
3.9
ratio
1.4
1.4
—
8
46
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
67
323
2.10
7.43
1.2
1.1
iu/ml
31.0
1806.5
0.52
14
73
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
106
602
1.79
7.29
1.9
3.9
mg/l
39.5
59.1
0.62
86
488
(3004119) Hemoglobin [Mass/volume] in Venous blood
183
1200
1.57
7.28
3.4
3.1
g/l
124.9
129.2
1.54
177
1170
(3022621) pH of Urine by Test strip
200
1338
1.54
7.28
3.2
2.9
—
—
—
0
0
(3039000) Anion gap in Blood
86
459
1.90
7.20
7.5
7.8
mmol/l
11.4
11.3
0.09
77
412
(3013293) Extractable nuclear Ab [Presence] in Serum
15
30
5.02
7.18
1.6
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
67
328
2.07
7.15
3.9
2.9
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
86
460
1.90
7.15
7.5
7.8
mmol/l
104.4
105.4
0.77
77
413
(3030313) Adrenal Ab [Titer] in Serum
10
13
7.72
7.12
1.0
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
31
106
2.95
7.12
1.9
1.3
umol/l
15.2
26.4
1.90
31
99
(3002256) Pathology report gross observation
356
2672
1.39
7.10
1.3
1.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
132
808
1.67
6.97
5.9
5.7
%
0.9
0.9
0.44
121
756
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
62
300
2.09
6.84
1.6
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
68
341
2.02
6.82
1.6
1.6
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
10
6
16.72
6.74
1.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
67
337
2.01
6.67
1.3
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
129
2022
0.62
6.60
1.3
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
48
213
2.28
6.56
4.2
6.2
mmol/l
7.8
7.3
0.44
35
179
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
71
367
1.96
6.56
1.6
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
547
4436
1.30
6.42
5.1
4.0
kg/l
1.0
1.0
0.34
91
620
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
51
235
2.19
6.39
1.7
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
1614
14812
1.24
6.37
4.4
3.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
39
160
2.46
6.35
1.5
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
76
408
1.89
6.29
2.4
2.1
nmol/l
0.8
0.8
0.37
62
338
(3004616) Nuclear Ab [Presence] in Serum
52
244
2.15
6.24
1.3
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
459
3649
1.31
6.22
1.3
1.3
iu/ml
34.2
33.8
0.03
156
1157
(3043409) Potassium [Moles/volume] in Arterial blood
105
625
1.71
6.18
5.1
3.8
mmol/l
3.9
3.9
0.47
97
590
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
21
62
3.41
6.14
3.3
2.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
34
134
2.56
6.03
2.7
2.8
%
41.4
38.6
0.32
13
40
(3006184) Hemoglobin [Mass/volume] in Capillary blood
79
436
1.84
6.02
3.2
2.2
g/l
122.5
130.9
2.40
58
319
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
13
27
4.83
5.97
1.8
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
192
1334
1.47
5.87
1.4
1.3
u/ml
151.1
209.7
0.90
173
1231
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
57
285
2.02
5.82
1.6
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
53
258
2.08
5.81
1.5
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
42
186
2.28
5.81
3.2
3.2
%
57.0
55.1
0.20
31
122
(40762365) Oxygen content in Arterial blood by calculation
14
32
4.39
5.76
5.7
2.7
ml/dl
13.7
15.8
1.97
14
27
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
438
3495
1.31
5.75
1.3
1.3
u/ml
8.5
11.9
0.48
142
1366
(3028433) Virus identified in Specimen by Culture
21
65
3.25
5.72
1.5
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
76
423
1.82
5.66
2.0
3.3
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
22
71
3.12
5.61
1.8
2.7
%
31.4
30.2
0.16
22
65
(3006245) CD3-CD19+ cells/100 cells in Blood
22
71
3.12
5.61
1.6
2.7
%
9.7
9.2
0.08
22
64
(3029634) Reagin Ab [Titer] in Serum by VDRL
57
291
1.98
5.51
3.4
2.1
titre
8.2
4.1
—
5
7
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
182
1268
1.47
5.50
3.9
3.3
pmol/l
4.4
4.5
0.56
169
1116
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
102
623
1.66
5.49
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
670
5667
1.25
5.45
1.9
1.7
mmol/l
1.5
1.4
1.08
580
4765
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
52
258
2.04
5.44
2.3
1.9
titre
6617.1
1220.0
—
7
8
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2038
19326
1.27
5.43
7.1
5.6
mmol/mol
40.7
39.6
3.15
1917
17921
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
61
322
1.92
5.36
1.6
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
16
43
3.74
5.36
1.1
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
36
155
2.34
5.33
1.2
1.1
u/ml
24.4
51.2
—
8
12
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
41
188
2.20
5.25
1.8
1.3
nmol/l
1.2
1.4
0.68
36
168
(21494814) CD8 cells/100 lymphocytes in Specimen
22
74
2.99
5.25
2.8
1.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
55
283
1.96
5.22
1.5
1.5
—
—
—
0
0
(3019225) pH of Specimen
268
2019
1.37
5.21
5.5
4.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
101
625
1.64
5.19
1.2
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
86
510
1.71
5.19
6.2
3.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
34
145
2.36
5.15
1.2
1.1
u/ml
28.2
3.8
—
5
10
(3017704) Immunofixation for Urine
29
115
2.54
5.12
1.2
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
101
631
1.63
5.01
1.2
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
39
180
2.18
4.94
1.7
1.3
—
—
—
0
0
(4010399)
201
1459
1.41
4.89
1.5
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
44
214
2.07
4.89
2.1
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
28
112
2.52
4.87
2.2
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
28
112
2.52
4.87
2.2
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
28
112
2.52
4.87
2.2
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
25
95
2.65
4.82
1.1
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
66
374
1.78
4.69
4.4
3.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
82
1316
0.61
4.68
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
267
2046
1.34
4.66
1.6
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
136
1955
0.68
4.65
1.6
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
76
450
1.71
4.65
1.9
4.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
39
186
2.11
4.57
1.8
1.3
e6/l
45219.6
112002.3
0.69
25
107
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
33
147
2.26
4.57
1.3
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
40
193
2.09
4.56
2.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
40
193
2.09
4.56
2.0
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
40
193
2.09
4.56
2.0
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
65
371
1.77
4.52
1.5
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
46
235
1.97
4.50
1.1
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
93
588
1.60
4.43
3.6
2.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
78
472
1.67
4.42
1.3
1.5
e6/l
367.9
1231.3
0.96
63
391
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
78
472
1.67
4.42
1.2
1.3
mmol/l
4.0
3.7
1.14
70
447
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
151
1061
1.45
4.41
2.6
2.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
129
879
1.49
4.41
1.2
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
27
112
2.43
4.38
2.2
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
33
150
2.22
4.37
1.3
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
17
55
3.10
4.36
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
31
139
2.24
4.24
2.5
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
23
90
2.57
4.21
2.3
1.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
57
320
1.80
4.21
1.4
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
204
1524
1.37
4.21
2.2
2.2
nmol/l
13.1
12.9
0.06
176
1362
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
77
472
1.65
4.17
1.2
1.5
e6/l
6.7
28.6
1.03
58
373
(3042631) Mycobacterium sp identified in Specimen
48
256
1.89
4.17
1.9
2.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
42
214
1.98
4.16
1.9
1.3
e6/l
6309.9
1781.9
0.79
30
148
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
45
235
1.93
4.16
2.1
1.7
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
48
257
1.88
4.12
2.8
1.4
mu/l
53.2
44.2
0.34
43
230
(1761868) Lipid panel - Serum or Plasma
663
7587
0.83
4.10
3.0
2.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
32
149
2.16
4.02
1.1
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
104
692
1.52
4.00
3.5
2.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
49
267
1.85
4.00
2.2
2.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2270
21994
1.29
3.92
25.0
12.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
110
746
1.50
3.88
3.4
2.2
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
8
11
7.29
3.86
1.1
1.9
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
8
11
7.29
3.86
1.4
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
110
749
1.49
3.81
3.5
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
22
89
2.48
3.79
2.4
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
22
89
2.48
3.79
2.4
1.9
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
43
229
1.89
3.78
1.8
1.4
g/l
30.3
33.2
0.59
36
203
(3013945) Hepatitis B virus e Ab [Presence] in Serum
7
8
8.77
3.77
1.1
2.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
28
127
2.22
3.76
1.5
1.4
u/l
7.5
6.0
0.46
23
107
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
34
3.54
3.76
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1442
13421
1.17
3.75
3.2
2.9
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
51
288
1.79
3.74
1.1
1.1
u/ml
2.1
2.7
0.23
11
130
(3003694) ABO and Rh group [Type] in Blood
665
5809
1.20
3.73
1.5
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
86
558
1.56
3.73
1.1
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
10
25
4.01
3.70
3.7
2.9
u/field
0.1
0.6
—
10
25
(3044927) Protein electrophoresis panel - Urine
40
210
1.92
3.68
1.1
1.1
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
24
103
2.34
3.66
1.5
1.4
u/l
1468.8
364.6
0.44
24
94
(3045414) Leukocytes [Presence] in Urine
134
956
1.42
3.66
2.0
1.9
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
9
16
5.64
3.65
4.7
2.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
18
67
2.70
3.65
1.0
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
116
806
1.46
3.65
2.5
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
108
742
1.48
3.60
3.5
2.2
—
—
—
0
0
(3019977) pH of Arterial blood
23
98
2.36
3.57
2.9
3.3
ph
7.4
7.4
—
8
32
(3006653) Thiamine [Moles/volume] in Blood
25
111
2.26
3.54
1.4
1.2
nmol/l
133.9
138.9
0.16
25
111
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
105
721
1.48
3.52
2.1
1.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
23
99
2.33
3.50
1.7
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
13
41
3.18
3.49
1.3
1.1
—
—
—
0
0
(3013512) EKG study
674
5932
1.18
3.44
4.1
3.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
23
100
2.31
3.43
1.7
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
144
1054
1.39
3.42
1.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
106
734
1.46
3.41
3.6
2.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
20
82
2.45
3.38
1.1
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
86
572
1.52
3.37
1.6
1.4
u/l
8.9
9.5
0.19
71
458
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
7
10
7.01
3.36
5.0
5.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
32
161
2.00
3.34
2.2
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
8
14
5.73
3.34
1.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
34
176
1.94
3.29
1.9
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
47
271
1.75
3.25
1.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
21
90
2.34
3.24
2.5
2.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
43
242
1.79
3.23
1.7
1.4
pmol/l
348.5
307.2
0.31
36
193
(40768446) Kidney Pathology biopsy report
20
84
2.39
3.22
2.0
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
16
60
2.68
3.22
1.3
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
36
192
1.89
3.20
1.4
1.7
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
8
15
5.35
3.19
1.0
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
23
104
2.22
3.15
11.7
7.1
u/ml
51.3
42.7
—
10
29
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
83
560
1.50
3.07
1.3
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
34
3.24
3.05
1.6
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
31
160
1.95
3.04
2.0
3.4
%
10.6
11.3
0.40
31
160
(3009871) Measles virus Ab [Titer] in Serum
17
68
2.51
3.04
1.5
1.6
—
—
—
0
0
(3020891) Body temperature
113
812
1.41
3.02
6.8
4.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
69
450
1.55
2.99
2.2
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
35
190
1.85
2.97
1.9
2.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
80
540
1.50
2.96
1.2
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
81
552
1.48
2.88
1.1
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
6
9
6.68
2.86
1.0
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
22
102
2.17
2.86
1.8
2.6
mmol/l
9.0
10.0
0.39
15
78
(3044290) Cell count panel - Cerebral spinal fluid
66
432
1.54
2.83
1.3
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
31
166
1.88
2.76
1.1
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
22
104
2.12
2.74
1.3
1.4
nmol/l
1.1
1.2
0.50
17
80
(3009542) Hematocrit [Volume Fraction] of Blood
2012
19414
1.17
2.71
30.5
14.5
%
39.2
39.9
4.21
1467
14151
(3014051) Protein [Presence] in Urine by Test strip
73
494
1.49
2.70
2.4
2.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
26
132
1.98
2.70
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
15
60
2.51
2.70
3.0
1.8
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
9
24
3.76
2.67
1.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
28
147
1.91
2.65
2.6
2.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
43
258
1.68
2.64
1.6
1.6
%
53.9
60.6
0.46
28
171
(3014271) Vancomycin [Susceptibility]
20
93
2.16
2.60
3.5
2.9
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
15
4.68
2.59
1.0
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
77
533
1.46
2.56
1.3
1.4
mg/l
470.0
512.6
0.73
70
504
(3039443) Prostate specific Ag panel - Serum or Plasma
23
436
0.52
2.55
1.4
1.6
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
34
193
1.77
2.54
1.5
1.5
%
36.6
30.3
0.40
21
123
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
239
1960
1.24
2.54
2.2
1.9
—
—
—
0
0
(3036603) Volume of Urine
26
136
1.92
2.50
1.8
1.4
—
1862.3
—
0
24
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
9
26
3.47
2.48
2.2
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
38
225
1.70
2.47
1.6
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
20
96
2.09
2.42
1.1
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
73
507
1.45
2.41
1.8
1.7
e6/l
18021.5
13797.5
0.31
58
369
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
45
281
1.61
2.40
1.2
1.3
nmol/l
0.6
0.7
0.19
45
266
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
12
5.01
2.40
1.0
1.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
8
6.26
2.37
1.2
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
8
6.26
2.37
1.2
1.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
5
8
6.26
2.37
10.8
4.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
218
1785
1.24
2.36
1.7
1.6
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
8
22
3.64
2.36
1.3
1.4
mmol/l
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
141
1097
1.30
2.33
4.6
3.5
u/ml
38.7
52.3
0.80
133
1054
(3008295) Osmolality of Serum or Plasma
35
207
1.70
2.30
1.5
1.4
mosm/kgh2o
276.8
278.7
0.16
29
151
(40768806) Pleura Pathology biopsy report
33
192
1.73
2.30
1.7
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
80
572
1.41
2.27
1.5
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
120
916
1.33
2.27
2.5
1.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
13
53
2.46
2.27
1.2
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
29
163
1.79
2.27
1.8
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
19
92
2.07
2.27
1.1
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
418
3658
1.17
2.24
1.5
1.5
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
5
9
5.56
2.21
1.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
9
5.56
2.21
1.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
35
210
1.68
2.20
1.2
2.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
259
2182
1.21
2.15
2.4
2.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
7
19
3.69
2.15
1.0
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
39
243
1.61
2.13
1.2
1.3
nmol/l
—
—
—
0
0
(40768793) Breast Pathology biopsy report
31
509
0.60
2.11
1.1
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
19
95
2.01
2.10
1.6
2.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
20
102
1.97
2.10
1.4
2.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
20
102
1.97
2.10
2.7
3.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
100
756
1.34
2.05
2.9
2.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
56
2.33
2.04
3.5
3.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
56
2.33
2.04
3.5
3.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
38
238
1.61
2.04
1.3
1.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
16
76
2.11
2.02
1.3
1.2
g/l
0.3
0.3
—
9
62
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
67
476
1.42
2.01
1.4
1.5
pmol/l
101.3
189.1
1.45
67
466
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
28
163
1.73
1.98
1.2
1.4
mmol/l
16.2
12.6
1.01
16
43
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
25
141
1.78
1.96
1.2
1.1
nmol/l
11.1
2.3
—
8
28
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
16
77
2.08
1.96
1.8
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
16
77
2.08
1.96
1.8
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
128
1009
1.28
1.96
3.5
3.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
326
3738
0.85
1.95
2.8
2.9
ug/l
0.6
0.7
6.47
211
2404
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
39
249
1.57
1.95
1.8
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
42
273
1.55
1.95
1.2
1.3
u/l
27.1
27.4
0.02
30
225
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2096
20418
1.15
1.94
5.3
4.4
mmol/l
6.1
5.9
5.52
1941
18651
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
45
2.45
1.93
1.0
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
45
2.45
1.93
1.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
11
45
2.45
1.93
2.4
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
19
99
1.93
1.90
1.5
1.3
—
—
—
0
0
(4034850)
48
697
0.68
1.89
22.5
9.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
7
22
3.19
1.88
2.0
2.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
39
252
1.56
1.87
1.9
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
9
34
2.65
1.86
1.2
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
19
100
1.91
1.85
1.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
38
245
1.56
1.84
1.9
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
38
245
1.56
1.84
1.9
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
40
261
1.54
1.84
1.2
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
39
253
1.55
1.84
1.9
1.4
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
17
3.53
1.83
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
21
115
1.83
1.82
1.2
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
68
494
1.39
1.82
2.4
2.4
ug/min
64.2
111.5
0.99
39
303
(3013762) Body weight Measured
5
12
4.17
1.82
1.4
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
49
335
1.47
1.82
1.6
1.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
14
66
2.13
1.81
1.3
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
113
887
1.29
1.81
1.5
1.4
iu/l
25.2
27.7
0.41
102
747
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
50
344
1.46
1.80
1.4
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
15
73
2.06
1.80
1.5
1.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
9
35
2.58
1.80
2.9
2.9
—
—
—
0
0
(3000012) Reticulocyte production index
18
94
1.92
1.80
1.4
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
38
247
1.55
1.78
1.9
1.4
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
10
41
2.44
1.75
1.2
1.3
—
145.8
—
0
8
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
41
2.44
1.75
1.5
2.8
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
27
162
1.67
1.74
1.1
1.1
mg/l
257.6
267.2
0.11
19
140
(3021387) Prolactin [Units/volume] in Serum or Plasma
94
724
1.31
1.74
1.9
1.6
mu/l
256.8
303.0
0.75
86
652
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
147
1.71
1.74
1.3
1.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(4306422)
46
315
1.47
1.71
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
98
762
1.30
1.70
1.6
1.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
68
2.06
1.70
1.2
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
87
666
1.32
1.69
2.1
2.2
u/l
6359.1
4272.1
0.21
29
268
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
42
2.39
1.67
1.2
1.0
—
—
—
0
0
(4027681)
23
135
1.71
1.62
1.4
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
33
213
1.56
1.62
2.5
1.7
ug/l
14.6
25.6
1.18
33
208
(3033705) Calcium.ionized [Moles/volume] in Venous blood
34
221
1.55
1.62
3.1
2.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
32
2.50
1.59
1.3
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
32
2.50
1.59
1.1
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
21
121
1.74
1.58
1.0
1.4
—
645.5
—
0
11
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
6
20
3.00
1.58
1.7
2.3
mg/l
1.0
1.4
—
6
15
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
46
321
1.44
1.57
1.2
1.2
u/ml
4.2
5.1
0.21
25
139
(21494434) Karyotype in Bone marrow
29
183
1.59
1.57
1.2
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
21
122
1.73
1.54
1.2
1.1
ratio
1.0
1.0
—
9
49
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
33
2.43
1.53
2.4
1.4
ng/l
209.0
120.5
—
8
33
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
20
115
1.74
1.52
1.7
1.6
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
15
3.34
1.52
1.6
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
15
3.34
1.52
1.6
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
44
307
1.44
1.52
1.1
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
27
169
1.60
1.52
1.1
1.2
mg/l
36.9
38.4
0.11
19
138
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
10
45
2.23
1.46
1.2
2.3
umol/l
21.6
16.5
—
10
45
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
16
87
1.84
1.45
1.2
1.1
u/ml
5.6
9.0
—
5
13
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
140
1160
1.22
1.45
2.5
1.8
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
28
2.50
1.45
1.3
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
16
3.13
1.44
1.0
1.0
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
14
73
1.92
1.43
1.2
2.2
%
215.6
154.6
0.92
14
68
(40761535) Cells panel - Urine sediment
198
1697
1.18
1.43
5.0
3.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
24
149
1.62
1.41
1.7
2.1
mmol/l
7.7
6.9
0.48
17
95
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
18
103
1.75
1.40
3.7
2.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
46
330
1.40
1.39
1.2
1.2
u/ml
1.9
3.3
0.82
22
109
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
38
264
1.45
1.36
1.2
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
17
2.94
1.36
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
49
360
1.37
1.30
1.4
1.6
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
24
2.50
1.30
1.2
1.1
—
—
—
0
0
(44806071)
6
24
2.50
1.30
1.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
68
526
1.30
1.29
2.0
1.9
iu/l
5.7
4.9
0.16
20
184
(3001019) Free T4 and TSH panel - Serum or Plasma
89
1103
0.80
1.28
1.7
1.7
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
18
2.78
1.28
1.0
1.3
u/l
10.4
13.4
—
5
18
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
32
218
1.47
1.28
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
165
1409
1.18
1.27
1.2
1.2
iu/ml
149.1
146.9
0.03
61
536
(3047007) Chlamydophila sp Ab [Presence] in Serum
42
302
1.40
1.27
1.2
1.2
—
—
—
0
0
(4015189)
11
55
2.00
1.27
1.3
2.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
19
115
1.66
1.24
1.7
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
115
1.66
1.24
1.2
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
36
2.23
1.24
1.1
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
13
70
1.86
1.23
1.2
2.4
ug/l
2.2
1.2
0.46
13
64
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
36
254
1.42
1.22
1.6
2.2
mg/l
17.8
24.6
0.59
11
73
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
262
2331
1.14
1.19
1.7
1.7
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
15
86
1.75
1.19
2.6
1.9
ug/l
24.3
109.4
0.45
15
77
(3023410) Appearance of Cerebral spinal fluid
31
214
1.45
1.18
1.2
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
133
1.58
1.17
1.7
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
18
110
1.64
1.15
1.2
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
20
2.50
1.15
1.2
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
35
0.00
1.15
0.0
5.7
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
16
95
1.69
1.13
1.4
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
30
2.34
1.12
8.4
9.9
mmol/l
5.0
6.3
—
7
30
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
21
2.38
1.09
1.4
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
21
2.38
1.09
1.6
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
31
218
1.43
1.09
1.2
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
12
66
1.82
1.09
1.2
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
154
1329
1.17
1.08
1.3
1.3
au/ml
34.7
54.4
—
5
61
(3022689) Creatine [Moles/volume] in Urine
11
59
1.87
1.07
1.5
1.5
—
—
—
0
0
(4268621)
31
220
1.41
1.04
2.3
2.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
28
195
1.44
1.04
1.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
160
1390
1.16
1.04
1.2
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
34
2.06
1.03
4.3
6.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
17
106
1.61
1.02
1.8
2.2
umol/l
47.3
52.6
—
10
84
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
83
1.69
1.01
1.2
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
14
83
1.69
1.01
1.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
53
1.89
1.01
1.2
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
9
49
1.84
0.98
1.0
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1842
18021
1.08
0.98
36.6
17.4
g/l
332.4
332.5
0.18
1832
17901
(3028717) Thiamine [Mass/volume] in Blood
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
23
2.18
0.98
1.2
2.8
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
43
328
1.32
0.95
1.0
1.1
—
11.1
—
0
19
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
34
456
0.74
0.95
1.6
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
20
133
1.51
0.94
1.2
1.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
118
0.51
0.94
1.3
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
27
2.22
0.93
1.2
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
23
159
1.45
0.91
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
29
2.07
0.89
1.3
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
6
29
2.07
0.89
1.2
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
166
1466
1.14
0.89
2.4
2.4
au/ml
11.7
24.5
—
7
85
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
479
5116
0.92
0.89
3.9
4.1
%
21.8
21.4
0.24
197
2405
(3002619) Bacteria identified in Specimen by Culture
8
42
1.91
0.88
1.1
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
30
2.00
0.87
1.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
44
1.82
0.85
2.0
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
44
1.82
0.85
1.1
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
88
1.59
0.84
1.5
1.7
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
8
45
1.78
0.84
1.8
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2038
20057
1.08
0.83
4.5
3.9
mmol/l
1.4
1.3
3.34
1891
18398
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
38
292
1.31
0.83
1.3
1.5
nmol/l
0.2
0.3
1.42
28
221
(3007461) Platelets [#/volume] in Blood
2374
23530
1.13
0.81
41.4
19.9
e9/l
246.3
252.1
3.20
2354
22961
(3024731) MCV [Entitic volume]
2375
23541
1.13
0.81
41.1
19.8
fl
91.2
90.9
1.49
2361
23224
(3035941) MCH [Entitic mass]
2375
23543
1.12
0.79
41.1
19.8
pg
30.3
30.3
0.44
2361
23224
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
2375
23545
1.12
0.78
41.3
19.9
e12/l
4.4
4.5
18.40
2350
22910
(3034426) Prothrombin time (PT)
11
66
1.67
0.78
1.3
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
58
475
1.23
0.77
4.3
4.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
68
811
0.83
0.76
1.5
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2375
23550
1.12
0.76
41.4
19.9
e9/l
6.9
6.7
2.63
2349
22914
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
53
1.70
0.75
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
53
1.70
0.75
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
53
1.70
0.75
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
53
1.70
0.75
1.0
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2375
23554
1.12
0.74
41.5
20.0
g/l
132.3
135.8
23.77
2361
23229
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
23
167
1.38
0.73
2.5
2.1
u/field
3.2
1.9
0.55
15
75
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
16
108
1.48
0.73
1.2
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
59
709
0.83
0.72
1.8
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
9
56
1.61
0.72
1.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
60
1.67
0.72
2.0
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
109
1.47
0.70
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
121
1067
1.14
0.70
1.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
26
1.92
0.70
2.2
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
14
93
1.51
0.69
1.2
1.7
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
27
1.85
0.68
1.4
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
27
1.85
0.68
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
76
886
0.85
0.68
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
87
753
1.16
0.66
1.1
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
28
1.79
0.66
1.0
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
28
1.79
0.66
1.0
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
28
1.79
0.66
1.0
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
32
250
1.28
0.65
1.1
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
18
128
1.41
0.65
2.2
2.1
ug/l
1.3
2.1
2.00
18
112
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
357
3350
1.08
0.63
1.5
1.4
—
—
—
0
0
(3016750) Collection duration of Urine
18
129
1.40
0.63
2.2
2.1
min
538.9
496.9
—
8
91
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
49
1.63
0.62
18.8
6.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
10
63
1.59
0.61
1.2
1.9
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
13
187
0.69
0.61
1.0
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
34
421
0.80
0.59
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
34
421
0.80
0.59
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
34
421
0.80
0.59
1.5
1.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
18
131
1.38
0.59
2.1
2.1
ug/l
2.1
3.4
1.16
18
118
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
72
1.53
0.59
2.1
2.4
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
23
0.00
0.58
0.0
1.6
—
7.0
—
0
8
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
34
420
0.81
0.58
1.5
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
30
376
0.80
0.58
1.1
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
35
1.72
0.57
1.5
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
39
319
1.23
0.57
1.1
1.1
—
—
—
0
0
(4024509)
25
194
1.29
0.55
2.2
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
12
82
1.47
0.54
1.2
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
96
0.62
0.52
1.2
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
15
109
1.38
0.51
1.1
1.2
—
—
—
0
0
(4146454)
28
225
1.25
0.49
2.7
2.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
29
355
0.81
0.48
1.5
1.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
21
164
1.28
0.46
2.0
2.3
ml
788.9
636.8
—
9
108
(3048879) Bone marrow aspiration report
7
51
1.37
0.44
2.7
2.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
19
148
1.29
0.43
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
56
1.43
0.42
1.0
1.0
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
15
0.00
0.41
0.0
9.9
—
191.4
—
0
10
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.1
—
0
7
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
0.1
—
0
8
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
13
172
0.75
0.40
1.2
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2110
20919
1.05
0.40
5.1
4.4
mmol/l
4.6
4.7
5.36
1984
19434
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
26
214
1.22
0.39
1.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
35
1.43
0.39
1.2
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
9
67
1.34
0.38
1.1
1.1
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
9
67
1.34
0.38
1.3
1.4
%
43.4
55.4
—
9
58
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
58
651
0.89
0.37
1.3
1.5
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
17
134
1.27
0.36
1.0
1.1
u/l
1.0
1.1
—
8
68
(3047352) Trisomy 18 risk [Likelihood] in Fetus
29
343
0.84
0.36
1.5
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
39
337
1.16
0.36
1.2
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
29
342
0.85
0.35
1.5
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
45
511
0.88
0.35
1.4
1.5
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
6
45
1.33
0.33
2.5
5.8
%
66.0
75.8
—
6
38
(3006462) Nitrate [Presence] in Urine
12
91
1.32
0.33
2.3
3.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
24
200
1.20
0.33
3.9
3.0
mg/l
152.9
39.7
0.75
15
150
(4211845)
13
100
1.30
0.33
3.0
3.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
265
2534
1.05
0.31
4.7
4.4
%
31.7
32.3
0.42
196
1700
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
29
249
1.17
0.30
1.3
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
30
260
1.16
0.28
2.2
1.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
94
1.28
0.28
1.4
1.8
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
8
63
1.27
0.27
1.0
1.2
%
—
21.4
—
0
9
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
117
0.77
0.27
1.6
1.3
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
75
0.67
0.25
1.0
1.3
nmol/l
17.1
33.3
—
5
59
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2091
20789
1.03
0.23
5.0
4.3
mmol/l
1.4
1.5
4.97
1947
19196
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
76
815
0.93
0.23
2.0
1.7
mg/l
4.7
4.2
0.11
56
566
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
40
1.25
0.22
1.0
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
41
1.22
0.22
1.0
1.3
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
4092.8
—
0
5
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
28
250
1.12
0.19
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
36
394
0.91
0.18
1.6
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
7
63
1.11
0.17
1.0
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
67
0.75
0.17
1.4
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
202
1958
1.03
0.16
1.4
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
13
111
1.17
0.15
2.5
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
73
1.10
0.15
1.1
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
78
0.77
0.15
21.7
14.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
27
245
1.10
0.15
1.0
1.1
u/ml
1.3
5.2
—
9
101
(3045683) HLA typing for celiac disease panel - Blood or Tissue
14
122
1.15
0.13
1.0
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
251
2565
0.98
0.12
13.0
6.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
19
171
1.11
0.12
1.1
1.3
u/ml
0.0
0.6
—
7
80
(3005570) Glucose [Moles/volume] in Urine
23
210
1.10
0.12
2.4
2.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
26
281
0.92
0.11
1.3
1.3
mmol/l
8.2
7.4
0.51
18
199
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
86
1.16
0.11
1.1
1.1
miu/ml
1312.7
1549.5
—
10
86
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
11
125
0.88
0.10
9.1
6.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
44
1.14
0.10
1.0
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
48
1.04
0.09
26.6
6.8
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
22
204
1.08
0.08
1.3
1.4
e6/l
35880.3
107986.1
0.76
16
140
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
62
0.81
0.08
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
63
0.79
0.08
1.2
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
66
1.06
0.08
3.1
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
72
0.83
0.07
1.0
1.3
—
—
—
0
0
(4094501)
62
599
1.04
0.07
1.1
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
84
1.07
0.07
3.0
4.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
39
373
1.05
0.07
1.2
1.1
u/ml
0.7
1.6
0.88
11
153
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
17
183
0.93
0.06
5.8
4.7
u/ml
17.6
57.8
—
5
52
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
28
295
0.95
0.06
1.4
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
101
0.89
0.06
1.7
1.8
—
—
—
0
0
(44813793)
15
140
1.07
0.04
1.1
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
34
331
1.03
0.02
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
34
331
1.03
0.02
1.1
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2130
21282
1.00
0.02
5.6
4.8
mmol/l
2.7
2.8
5.78
1982
19656
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
72
728
0.99
0.01
1.8
1.9
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
34
333
1.02
0.01
1.1
1.1
u/ml
5.7
5.0
0.08
13
170
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
10
106
0.94
0.01
1.2
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
636
6365
1.00
0.00
4.5
4.7
ug/l
5.3
2.6
0.54
566
5727
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
35
348
1.01
0.00
2.1
1.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
32
321
1.00
0.00
1.1
1.1
u/ml
0.3
1.7
—
10
136
(3051387) C reactive protein [Mass/volume] in Capillary blood
44
443
0.99
0.00
4.6
3.5
mg/l
35.9
25.3
1.11
30
272
(3014133) Dog dander IgE Ab [Units/volume] in Serum
27
272
0.99
0.00
1.0
1.1
u/ml
2.0
2.9
—
7
106
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
65
0.92
0.00
1.3
1.1
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
7
69
1.01
0.00
1.6
1.5
pmol/l
14.1
15.6
—
7
56
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
7
0.00
0.00
0.0
6.4
—
82.0
—
0
7
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
68
0.88
0.00
1.3
1.1
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
58
0.86
0.00
1.0
1.6
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
1.4
—
0
9
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint K11_OTHINFLIV and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_OTHINFLIV | 2.225 [2.0, 2.48] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.051 |
During the follow-up period (1.1.1998 — 31.12.2019), 1869 out of 7701 females with K11_OTHINFLIV died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_OTHINFLIV | 2.653 [2.38, 2.96] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.017 |
During the follow-up period (1.1.1998 — 31.12.2019), 2097 out of 6647 males with K11_OTHINFLIV died.
Mortality risk
Mortality risk for people of age
years, who have K11_OTHINFLIV.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.17% | 0.497% |
| 5 | 1.218% | 3.408% |
| 10 | 2.785% | 7.77% |
| 15 | 5.34% | 13.998% |
| 20 | 9.612% | 24.056% |
Relationships between endpoints
↥Index endpoint: K11_OTHINFLIV – Other inflammatory liver diseases
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data